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Two defensins, α-defensin 5 and 6 (HD5 and HD6, respectively), are produced in the approximately 16-foot-long small intestine in adults, where nutrient absorption takes place through the intestinal epithelium following food and drink consumption. 2 In this niche, where numerous molecules are constantly in transit across the epithelium, intestinal Paneth cells secrete HD5 and HD6 along with lysozyme, for example, to attempt to prevent access to microorganisms that can cause acute food-borne illness as well as complicated systemic infections. HD5 acts molecularly to kill bacterial pathogens. HD6, on the other hand, has not been observed to exhibit antimicrobial activity but gained attention in 2012 when it was discovered to oligomerize and assemble into "nanonets" to entangle and trap bacteria, preventing intimate contact with epithelial cells and cell invasion. 3 The HD6 nanonets are visually striking, akin to the spider web-like biofilm networks produced by bacteria and fungi to enmesh microbial communities. Between 2012 and 2016, HD6 was demonstrated to inhibit host-cell invasion by Salmonella 3 and Listeria monocytogenes. C. albicans biofilm formation, invasion of the intestinal epithelium, and the consequences of systemic fungal infection present a serious challenge to the host, particularly with the increase in C. albicans resistance to antifungal drugs. All promising anti-infective strategies warrant thorough and creative exploration capable of ultimately introducing either immuneboosting or antimicrobial or antivirulence therapeutics. It is common to look to polymicrobial communities for design strategies that have evolved among microbes in a kind of interbacterial warfare setting to eradicate or influence neighboring microbial populations. Here we find an exciting example of a human defense system that inhibits virulence traits of C. albicans without cell killing. Such a strategy might help to maintain the physiologically beneficial balance of microbes in the gut microbiome while preventing the undesired consequences associated with cells that can undergo a transition to a pathogenic lifestyle and become poised to invade or colonize intestinal mucosa.
The authors suspect that a general mode of action may be at work to allow HD6 nanonets to interact with and entangle C. albicans as well as other microbes, including Gram-negative Salmonella species and the Gram-positive bacterium L. monocytogenes. This possibility brings to light the likeness of nanonets with other web-like materials involving microbes. Biofilm aficionados will note the striking similarities between electron micrographs of these host-derived nanonets and the web-like extracellular matrix materials produced by bacteria in self-entangling and often protective bacterial communities. Biofilm matrix components can vary widely among biofilmforming organisms but function similarly at a broad level, promoting cohesion and entanglement among resident microbes. Nanonets also resemble neutrophil extracellular traps, termed NETs, 5 in both physical likeness and function. NETs are composed of fibrous materials, primarily DNA from neutrophils, and serve to immobilize and contain invading microorganisms, aiding in their ultimate demise. Further work may identify specific molecular attributes that are uniquely suited to these distinct macromolecular nets and networks and may reveal more specific functional correlates beyond their general adhesive and cohesive functions. The collective discoveries by Chairatana et al. demonstrate for the first time that HD6 can prevent key steps in C. albicans pathogenesis. The anti-adhesion and anti-biofilm functions ascribed to HD6 Viewpoint pubs.acs.org/biochemistry and the sequence-specific attributes of HD6 as compared to other defensins will fuel future work that will aim to investigate the molecular advantages of deploying HD6 nanonets in the intestinal niche to maintain a healthy microbiome and defend against pathogens.
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